| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 02/15/2005 | US6855825 Short synthesis of pyridine-based pharmaceutical intermediates |
| 02/15/2005 | US6855722 Substituted indoles and their use as integrin antagonists |
| 02/15/2005 | US6855715 Drugs such as 1-(3-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4-(4-fluoro-2 -methylsulphonylphenyl)piperazine, used as anticoagulants |
| 02/15/2005 | US6855709 Psychological disorders; central nervous system disorders |
| 02/15/2005 | CA2110828C Transition metal complexes having 2,2'-bipyridine ligands substituted by at least one ammonium alkyl radical, their method of manufacture and use thereof as a redox mediator |
| 02/10/2005 | WO2005012287A1 Therapeutic agents useful for treating pain |
| 02/10/2005 | WO2005012280A1 Alkynyl aryl carboxamides |
| 02/10/2005 | WO2005012250A1 Process for production of pyridylethylthio compounds, modified ion exchangers, process for production thereof, and process for production of bisphenols |
| 02/10/2005 | WO2005012241A2 p-38 KINASE INHIBITORS |
| 02/10/2005 | WO2005012234A1 Compounds for modulating cell proliferation |
| 02/10/2005 | WO2005012228A1 O-coordinated metal chelates and their use in optical recording media having high storage capacity |
| 02/10/2005 | WO2005012221A1 Diphenyl ether compound, process for producing the same, and use |
| 02/10/2005 | WO2005012220A2 Cycloalkylidene compounds as modulators of estrogen receptor |
| 02/10/2005 | WO2005011656A2 Pyridyl derivatives and their use as therapeutic agents |
| 02/10/2005 | WO2005011654A2 Pyridyl derivatives and their use as therapeutic agents |
| 02/10/2005 | WO2005011653A2 Pyridazine derivatives and their use as therapeutic agents |
| 02/10/2005 | WO2004110983A3 New benzamides as pparϒ modulators |
| 02/10/2005 | US20050033076 Coordination polymerization catalysts |
| 02/10/2005 | US20050033040 Self-dispersible bipyridine-based metal complex and ink composition comprising the same |
| 02/10/2005 | US20050033006 New catalysts for selective isocyanate dimerization |
| 02/10/2005 | US20050032849 Substituted small-molecule arylthiourea compounds are potent and/or selective inhibitors of viral replication in vivo, particularly Hepatitis C virus replication; e.g., 1-(3-benzyloxy)phenylthiourea; side effect reduction |
| 02/10/2005 | US20050032848 Administering enzyme inhibitors of beta secretase, an enzyme responsible for the production of amyloid beta peptide by mediating the cleavage of amyloid precursor proteins; Alzheimer's disease; cognition activators; Down's syndrome; neurodegenerative diseases; other dementias of mixed origins |
| 02/10/2005 | US20050032847 Enzyme inhibitors of nitric oxide synthase; central nervous system disorders; analgesics; cardiovascular disorders; headaches; antiinflammatory, -carcinogenic and -ulcer agents; stroke; analgesics; shock; reperfusion injury; Crohn's and Alzheimer's and neurodegenerative diseases; multiple sclerosis |
| 02/10/2005 | US20050032845 1,1-and 1,2-disubstituted cyclopropane compounds |
| 02/10/2005 | US20050032838 Nicotinamide derivatives useful as PDE4 inhibitors |
| 02/10/2005 | US20050032822 E.g., 5-dinitro-2-dimethyldithio-carbamoyl-pyridine; strong bacteriacidal activity, especially against mycobacteria; tuberculosis and leprosy caused by mycobacteria and infectious diseases caused by staphylococci; side effect reductions; effective against drug, multidrug-resistant infections |
| 02/10/2005 | US20050032820 Novel spiro compounds |
| 02/10/2005 | US20050032816 N-oxide anthranylamide derivatives and their use as medicaments |
| 02/10/2005 | US20050032805 Antimicrobial biaryl compounds |
| 02/10/2005 | US20050032798 Diaryl ureas, which release urea compound when administered to patient, for example, 1-(4-chloro-3(trifluoromethyl)phenyl)-3-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)-2-oxo-(1,3,5-perhydrotriazapine); treatment of cancer, inflammation |
| 02/10/2005 | US20050032794 For example, 2-Dimethylamino-N-(3-dimethylamino-1,4-dioxo-1,4-dihydro-naphthalen-2-yl)-N-methyl-acetamide; ability to function as gene expression modulators for genes found in cancer cells, especially genes involved in misregulated signal transduction pathways typical of cancers of colon and breast |
| 02/10/2005 | US20050032790 For example, 1-(2-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4,4'-bispiperidine; for treatment of thrombosis, emphysema, cirrhosis; antiarthritic agents, anticancer agents, antihistamines |
| 02/10/2005 | US20050032787 Pheny (alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity |
| 02/10/2005 | US20050032746 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 02/10/2005 | US20050032651 6-(1,1-Difluoroalkyl)-4-aminopicolinates and their use as herbicides |
| 02/10/2005 | US20050031904 Light-emitting device and iridium complex |
| 02/10/2005 | US20050031903 Multilayer; charge generating compound, charge transfer compound; blue phosphorescence |
| 02/10/2005 | US20050028300 Use of tetra-azapentamethine compounds as direct dyeing agents and novel tetraazapentamethine compounds |
| 02/10/2005 | CA2534990A1 P-38 kinase inhibitors |
| 02/10/2005 | CA2534127A1 Substituted benzothiophene compounds and uses thereof |
| 02/10/2005 | CA2533900A1 Pyridyl derivatives and their use as therapeutic agents |
| 02/10/2005 | CA2533898A1 Pyridyl derivatives and their use as therapeutic agents |
| 02/10/2005 | CA2533897A1 Pyridazine derivatives and their use as therapeutic agents |
| 02/10/2005 | CA2533287A1 Compounds for modulating cell proliferation |
| 02/10/2005 | CA2527861A1 Alkynyl aryl carboxamides |
| 02/09/2005 | EP1505054A1 Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative |
| 02/09/2005 | EP1504762A1 Medicine for prevention of and treatment for amyloidosis |
| 02/09/2005 | EP1504002A1 OPTICALLY ACTIVE &bgr;-AMINOKETONES, OPTICALLY ACTIVE 1,3-AMINOALCOHOLS AND METHOD FOR THE PRODUCTION THEREOF |
| 02/09/2005 | EP1503997A1 Cysteine protease inhibitors |
| 02/09/2005 | EP1503995A2 Method for producing substituted phenylsulfonyl urea |
| 02/09/2005 | EP1503986A2 Compositions and methods for treating heart failure |
| 02/09/2005 | EP1503981A2 Substituted tetracycline compounds |
| 02/09/2005 | EP1503761A1 Substituted piperazines as melanocortin receptor ligands |
| 02/09/2005 | EP1427704B1 Method for producing 4-haloalkylnicotinic acid esters |
| 02/09/2005 | EP1204322B1 Fungicides |
| 02/09/2005 | EP1200076A4 Calcilytic compounds |
| 02/09/2005 | EP1191008B1 Compound having tetrahydronaphthalene skeleton and liquid crystal composition containing the same |
| 02/09/2005 | EP1150960B1 Polymorphic crystalline forms of celecoxib |
| 02/09/2005 | EP1062251B1 Polymerisation catalyst |
| 02/09/2005 | EP0900210B1 Antivirally active heterocyclic azahexane derivatives |
| 02/09/2005 | CN1578770A Process for the production of heteroaromatic nitriles improved catalyst therefor and a process for the production of said improved catalyst |
| 02/09/2005 | CN1578769A Processes for the manufacturing of 3-hydroxy-n, 1, 6-trialkyl-4-oxo-1, 4-dihydropyridine-2-carboxamide |
| 02/09/2005 | CN1578768A Anthranilic acid amides and pharmaceutical use thereof |
| 02/09/2005 | CN1578663A Inhibitors of histone deacetylase |
| 02/09/2005 | CN1578662A Pyridine derivatives as nmda-receptor subtype blockers |
| 02/09/2005 | CN1578659A Modulators of peroxisome proliferator activated receptors (ppar) |
| 02/09/2005 | CN1578557A Organometallic complex and organic electroluminescent device employing the same |
| 02/09/2005 | CN1575816A Compounds for the treatment of female sexual dysfunction |
| 02/09/2005 | CN1188401C Heterocyclic amide compound and its pharmaceutical use |
| 02/09/2005 | CN1188397C Process for preparation of acid chloride compounds |
| 02/09/2005 | CN1188396C New process for producing 4-(4-pyridy1) benzoic acid or its salt |
| 02/08/2005 | US6853472 Electrolytes for electrooptic devices comprising ionic liquids |
| 02/08/2005 | US6852863 Osteoporosis; immunosuppressants; wound healing agent |
| 02/08/2005 | US6852859 Economic and environmentally clean process for the preparation of the pyridinium salt of fluorotrioxo-chromate (VI), PFC, having the chemical formula C5H5NH(CrO3F), by direct reaction of stoichiometric amounts of hydrofluoric acid, chromium |
| 02/08/2005 | US6852761 Inhibitors of serine proteases of the coagulation cascade and compounds, compositions and methods for anticoagulant therapy for the treatment and prevention of a variety of thrombotic conditions including coronary artery and cerebrovascular |
| 02/08/2005 | US6852751 Difluorobutyric acid metalloprotease inhibitors |
| 02/08/2005 | US6852742 To modulate the activity of calcium channels, therapy of cardiovascular disease or neurological disorders, that are associated with calcium channels |
| 02/08/2005 | US6852717 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor; for use in therapy of diseases and pathological conditions involving inflammation such as chronic inflammatory disease |
| 02/08/2005 | US6852711 HIV protease inhibitors |
| 02/08/2005 | US6852673 Herbicidal pyridine compounds |
| 02/08/2005 | US6852249 Luminescence emission |
| 02/08/2005 | US6852229 Filtration; for prevention of destruction of catalyst |
| 02/08/2005 | CA2310302C Method of producing an optically active .beta.-hydroxy sulfonic acid compound by catalytic asymmetric hydrogenation |
| 02/08/2005 | CA2130754C Amine derivatives of oxo- and hydroxy-substituted hydrocarbons |
| 02/08/2005 | CA2096525C Retroviral protease inhibitors |
| 02/08/2005 | CA2096409C Retroviral protease inhibitors |
| 02/08/2005 | CA2096408C Retroviral protease inhibitors |
| 02/03/2005 | WO2005010011A2 Methods of synthesis of acyloxyalkyl compounds |
| 02/03/2005 | WO2005009978A1 2-aminopyrimidine and 2-aminopyridine-4-carbamates for use in the treatment of autoimmune diseases |
| 02/03/2005 | WO2005009966A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 02/03/2005 | WO2005009965A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 02/03/2005 | WO2005009964A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 02/03/2005 | WO2005009963A1 Chelants and macrocyclic metal complex radiopharmaceuticals tihereof |
| 02/03/2005 | WO2005009961A2 Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions |
| 02/03/2005 | WO2005009941A1 Indane derivates as muscarinic receptor agonists |
| 02/03/2005 | WO2005009940A1 Novel aminobenzophenone compounds |
| 02/03/2005 | WO2005009928A2 Preparation and use of alkylating agents |
| 02/03/2005 | WO2005009479A1 Radiolabeled cannabinoid-1 receptor modulators |
| 02/03/2005 | WO2005009443A1 2-amino-4-hydroxy-5-pyrimidinecarboxamide derivatives and related compounds as inhibitors of t cell activation for the treatment of inflammatory diseases |
| 02/03/2005 | WO2005009104A2 Benzoic and phenyl acetic acid derivatives as hnf-4 modulators |